相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Molecular analysis of 10 pleomorphic rhabdomyosarcomas reveals potential prognostic markers and druggable targets
Zachary L. Chelsky et al.
GENES CHROMOSOMES & CANCER (2022)
Identification of a novel RAB3IP-HMGA2 fusion transcript in an adult head and neck rhabdomyosarcoma
Alessandro De Vita et al.
ORAL DISEASES (2022)
Chemerin promotes proliferation and migration of ovarian cancer cells by upregulating expression of PD-L1
Chenxi Gao et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2022)
Immune suppressive function of IL-1α release in the tumor microenvironment regulated by calpain 1
Dandan Lin et al.
ONCOIMMUNOLOGY (2022)
Non-coding RNA in rhabdomyosarcoma progression and metastasis
Farah Ramadan et al.
FRONTIERS IN ONCOLOGY (2022)
Advances in the treatment of pediatric solid tumors: A 50-year perspective
Michael P. LaQuaglia et al.
JOURNAL OF SURGICAL ONCOLOGY (2022)
TNF in the era of immune checkpoint inhibitors: friend or foe?
Allen Y. Chen et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
Jinhua Liu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Ectopic CD137 expression by rhabdomyosarcoma provides selection advantages but allows immunotherapeutic targeting
Kang Yi Lee et al.
ONCOIMMUNOLOGY (2021)
Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas
Alessandro De Vita et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Biology and therapeutic potential of interleukin-10
Margarida Saraiva et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
The current landscape of rhabdomyosarcomas: an update
Julia Leiner et al.
VIRCHOWS ARCHIV (2020)
Chemerin Reactivates PTEN and Suppresses PD-L1 in Tumor Cells via Modulation of a Novel CMKLR1-mediated Signaling Cascade
Keith Rennier et al.
CLINICAL CANCER RESEARCH (2020)
Chemerin Isoform-Specific Effects on Hepatocyte Migration and Immune Cell Inflammation
Susanne Feder et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies
Valerio Gelfo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Chemerin Isoforms and Activity in Obesity
Christa Buechler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Chemerin and Cancer
Oliver Treeck et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer
Kerry B. Goralski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Chemerin acts via CMKLR1 and GPR1 to stimulate migration and invasion of gastric cancer cells: putative role of decreased TIMP-1 and TIMP-2
Dinesh J. Kumar et al.
Oncotarget (2019)
Rhabdomyosarcoma
Stephen X. Skapek et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Inflammation and Cancer
Nitin Singh et al.
ANNALS OF AFRICAN MEDICINE (2019)
Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis
Jing-Jing Li et al.
BRITISH JOURNAL OF CANCER (2018)
Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention
Woo Jae Shin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Expression of chemerin correlates with a poor prognosis in female breast cancer patients
Ghada El-Sagheer et al.
BREAST CANCER-TARGETS AND THERAPY (2018)
Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation
Y. Lin et al.
ONCOGENE (2017)
Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy
Hui Xiao et al.
PLOS ONE (2017)
Rhabdomyosarcoma, Spindle Cell/Sclerosing Variant: A Clinical and Histopathological Examination of this Rare Variant with Three New Cases from the Oral Cavity
Molly Housley Smith et al.
HEAD & NECK PATHOLOGY (2017)
Assessment of Programmed Death-Ligand 1 Expression and Tumor-Associated Immune Cells in Pediatric Cancer Tissues
Robbie G. Majzner et al.
CANCER (2017)
From mice to humans: developments in cancer immunoediting
Michele W. L. Teng et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Overexpression of chemerin was associated with tumor angiogenesis and poor clinical outcome in squamous cell carcinoma of the oral tongue
Ning Wang et al.
CLINICAL ORAL INVESTIGATIONS (2014)
Gpr1 is an active chemerin receptor influencing glucose homeostasis in obese mice
Jillian L. Rourke et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo
Jane Renshaw et al.
CLINICAL CANCER RESEARCH (2013)
Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis
Mark E. Issa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Chemerin regulates proliferation and differentiation of myoblast cells via ERK1/2 and mTOR signaling pathways
Huansheng Yang et al.
CYTOKINE (2012)
The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses
Russell K. Pachynski et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism
Benjamin Bondue et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Chemerin Exacerbates Glucose Intolerance in Mouse Models of Obesity and Diabetes
Matthew C. Ernst et al.
ENDOCRINOLOGY (2010)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells
Chun-Liang Chen et al.
BMC CANCER (2007)